Egypt Liver Diseases Therapeutics Market Analysis

Egypt Liver Diseases Therapeutics Market Analysis


$ 3999

By 2030, it is anticipated that the Egypt Liver Disease Therapeutics market will reach a value of $113 Mn from $65 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Egypt is dominated by domestic pharmaceutical companies such as Pharco Pharmaceuticals, Delta Pharma, and EIPICO. The Liver Disease Therapeutics market in Egypt is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Egypt Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.

ID: IN10EGPH040 CATEGORY: Pharmaceuticals GEOGRAPHY: Egypt AUTHOR: Dr. Vishwa Modhia

Buy Now

Egypt Liver Disease Therapeutics Analysis Summary

By 2030, it is anticipated that the Egypt Liver Disease Therapeutics market will reach a value of $113 Mn from $65 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030.

Egypt is a lower middle-income, developing country in North Africa that borders the Red Sea and the Mediterranean Sea. According to the latest WHO data published in 2020 Liver Disease Deaths in Egypt reached 60,122 or 11.20% of total deaths. The age-adjusted Death Rate is 93.37 per 100,000 population ranks Egypt 1st in the world.

The Egyptian Ministry of Health has recently suggested a new national strategy to control the HCV pandemic in Egypt with a higher capital fund and with help from the WHO as well as other agencies. Citation19 This programme, dubbed "The Plan of Action for the Prevention, Care, and Treatment of Viral Hepatitis 2014-2018," pushed sofosbuvir. Egypt's government spent 4.4% of its GDP on healthcare in 2020.

Egypt Liver Disease Therapeutics Analysis

Market Dynamics

Market Growth Drivers Analysis

In Egypt, various care programmes have been designed to combat liver disorders such as schistosomiasis and viral hepatitis. Hepatitis A is one of the most common diseases in Egypt. Viral liver disease is caused by the hepatitis A virus. Interferon treatment was prohibitively expensive, especially for Egypt's primarily impoverished patient population, resulting in irregular access to treatment. With the medicine producer, the Egyptian government successfully negotiated considerable price reductions for direct-acting antiviral (DAA) drugs. Egypt reduced prices even more by allowing local, generic competition. This enabled the Egyptian government to tackle the outbreak on a scale that would have been impossible otherwise. These aspects could boost Egypt's Liver Disease Therapeutics market.

Market Restraints

One of the most pressing issues for the Egyptian people, however, is available of these medical therapies, especially given that Egypt's HCV pandemic is predominantly socioeconomic in character. Some innovative medicines have demonstrated an efficacy of higher than 90%. However, the expense of these new drugs is a significant obstacle to their availability. With a growing population, limited resources, and a lack of infection control techniques, Egypt still confronts serious disease management concerns today. These factors may deter new entrants into the Egypt Liver Disease Therapeutics market.

Competitive Landscape

Key Players

  • EIPICO: Egyptian International Pharmaceutical Industries Company (EIPICO) is a leading pharmaceutical company in Egypt that produces a wide range of therapeutic products, including those for liver disease
  • Delta Pharma: Delta Pharma is an Egyptian pharmaceutical company that produces a variety of therapeutics, including those for liver disease
  • Memphis Pharmaceutical and Chemical Industries: Memphis Pharmaceutical and Chemical Industries is an Egyptian pharmaceutical company that develops and produces a range of therapeutic products, including those for liver disease
  • Pharco Pharmaceuticals: Pharco Pharmaceuticals is an Egyptian pharmaceutical company that produces a range of therapeutics, including those for liver disease
  • Amoun Pharmaceutical Company: Amoun Pharmaceutical Company is an Egyptian pharmaceutical company that develops and produces a wide range of therapeutic products, including those for liver disease

Healthcare Policies and Reimbursement Scenarios

Egypt approved the Universal Health Insurance (UHI) bill in 2018 to attain universal health coverage as part of Transforming Egypt's Healthcare System Project. The goal of the UHI law is to cover the entire population by securing money through innovative and diverse finance channels. The adoption of Egypt's UHI law shows the country's progress toward universal health care, and it is the culmination of extensive and concerted efforts by the Egyptian government and major stakeholders, including the World Health Organization (WHO). The Egyptian Drug Authority (EDA) and the Ministry of Health and Population oversee the regulation and reimbursement of liver treatments in Egypt.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Liver Disease Therapeutics Segmentation

By Treatment Type (Revenue, USD Billion):

  • Chemotherapy
  • Antiviral Drugs
  • Vaccines
  • Immunosuppressants
  • Corticosteroids
  • Immunoglobulins
  • Targeted Therapy

By Disease Type (Revenue, USD Billion):

  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Autoimmune Diseases
  • Cancer
  • Hepatitis
  • Genetic Disorder
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 23 March 2023
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up